Jyong Biotech (MENS) Cash Flow: Operating & Free Cash Flow

Jyong Biotech Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Jyong Biotech Ltd. (MENS) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Operating Activities
Net Income	-4.67	-3.02	-4.40	-6.63	-4.20	-1.92
Depreciation & Amortization	0.10	0.12	0.13	0.12	0.12	0.11
Change in Working Capital	20.74	-1.49	1.12	2.94	1.24	-0.08
Change in Accounts Payable	0.00	0.00	0.00	-0.03	0.01	-0.10
Change in Other Working Capital	-19.20	0.76	1.12	3.14	0.97	0.14
Other Operating Activities	-19.20	0.76	0.55	0.60	0.85	0.80
Net Cash from Operating Activities	-3.04	-3.62	-2.60	-2.97	-1.98	-1.09
Investing Activities
Capital Expenditures	0.00	0.00	0.00	-0.25	-0.14	-0.09
Purchases of Investments	-16.87	0.00	0.00	-0.29	-1.83	-0.66
Sales/Maturities of Investments	16.87	0.00	0.10	1.93	0.66	1.48
Other Investing Activities	-13.51	0.00	0.00	0.00	0.00	0.82
Net Cash from Investing Activities	-13.51	0.00	0.10	1.39	-1.31	0.73
Financing Activities
Debt Repayment	-24.50	-9.47	2.47	-0.29	-1.45	-0.10
Common Stock Issued	17.77	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	-0.11	-0.21	-0.45	-0.28	-0.04	0.04
Net Cash from Financing Activities	17.63	1.99	2.03	3.33	-1.38	4.91
Summary
Effect of Forex Changes on Cash	-0.01	-0.01	-0.05	-0.03	0.07	0.14
Net Change in Cash	1.08	-1.64	-0.53	1.72	-4.61	4.70
Cash at Beginning of Period	0.10	1.74	2.27	0.55	5.16	0.00
Cash at End of Period	1.18	0.10	1.74	2.27	0.55	5.16
Free Cash Flow	-3.04	-3.62	-2.60	-3.22	-2.12	-1.18
Supplemental Disclosures
Interest Paid	-	0.22	0.10	0.16	0.11	0.09

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Jyong Biotech Cash Flow

What is Jyong Biotech's free cash flow?

Jyong Biotech had negative free cash flow of $3.04M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Jyong Biotech pay dividends or buy back shares?

Jyong Biotech's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition